ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008

Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program

July 23, 1999

ACS California Division Offers Fellowships For Clinical Research

June 14, 1996

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Study Finds Trial Results Reliable At Three Years

July 29, 2005

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989